Reported Standalone quarterly numbers for Prism Medico and Pharmacy are:Net Sales at Rs 4.32 crore in March 2021 down 9.57% from Rs. 4.78 crore in March 2020.
Quarterly Net Loss at Rs. 0.81 crore in March 2021 down 247.94% from Rs. 0.23 crore in March 2020.
EBITDA stands negative at Rs. 0.85 crore in March 2021 down 269.57% from Rs. 0.23 crore in March 2020.
Prism Medico shares closed at 8.67 on April 28, 2021 (BSE) and has given -58.71% returns over the last 6 months and -35.73% over the last 12 months.
| Prism Medico and Pharmacy | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'21 | Dec'20 | Mar'20 | | Net Sales/Income from operations | 4.32 | 6.07 | 4.78 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 4.32 | 6.07 | 4.78 | | EXPENDITURE | | Consumption of Raw Materials | 9.79 | -- | -- | | Purchase of Traded Goods | -- | 5.70 | -- | | Increase/Decrease in Stocks | -4.80 | 0.00 | 5.07 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.16 | 0.00 | -0.04 | | Depreciation | 0.00 | 0.00 | -- | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.02 | 0.01 | -0.02 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.85 | 0.35 | -0.23 | | Other Income | -- | -- | -- | | P/L Before Int., Excpt. Items & Tax | -0.85 | 0.35 | -0.23 | | Interest | 0.00 | -- | 0.00 | | P/L Before Exceptional Items & Tax | -0.85 | 0.35 | -0.23 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.85 | 0.35 | -0.23 | | Tax | -0.04 | 0.09 | -- | | P/L After Tax from Ordinary Activities | -0.81 | 0.26 | -0.23 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.81 | 0.26 | -0.23 | | Equity Share Capital | 6.06 | 6.06 | 6.06 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.13 | 0.04 | -0.03 | | Diluted EPS | -0.13 | 0.04 | -0.03 | | EPS After Extra Ordinary | | Basic EPS | -0.13 | 0.04 | -0.03 | | Diluted EPS | -0.13 | 0.04 | -0.03 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
